Barriers towards effective pharmacovigilance systems of biosimilars in rheumatology: A Latin American survey

por Castañeda‐Hernández, Gilberto, Sandoval, Hugo, Coindreau, Javier, Rodriguez‐Davison, Luis Felipe, Pineda, Carlos
Publicado 2019

Cost-Effectiveness of Early Treatment with Originator Biologics or Their Biosimilars After Methotrexate Failure in Patients with Established Rheumatoid Arthritis

por Patel, Dipen, Shelbaya, Ahmed, Cheung, Raymond, Aggarwal, Jyoti, Park, Sang Hee, Coindreau, Javier
Publicado 2019

Clinical and regulatory perspectives on biosimilar therapies and intended copies of biologics in rheumatology

por Mysler, Eduardo, Pineda, Carlos, Horiuchi, Takahiko, Singh, Ena, Mahgoub, Ehab, Coindreau, Javier, Jacobs, Ira
Publicado 2016

Switching Between Reference Biologics and Biosimilars for the Treatment of Rheumatology, Gastroenterology, and Dermatology Inflammatory Conditions: Considerations for the Clinician

por Moots, Robert, Azevedo, Valderilio, Coindreau, Javier L., Dörner, Thomas, Mahgoub, Ehab, Mysler, Eduardo, Scheinberg, Morton, Marshall, Lisa
Publicado 2017